0001209191-11-016770.txt : 20110309 0001209191-11-016770.hdr.sgml : 20110309 20110309194753 ACCESSION NUMBER: 0001209191-11-016770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110302 FILED AS OF DATE: 20110309 DATE AS OF CHANGE: 20110309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRAZAN JEFFREY M CENTRAL INDEX KEY: 0001032623 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 11676460 MAIL ADDRESS: STREET 1: 2884 SAND HILL RD STE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 c13907_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2011-03-02 0001080014 THERAVANCE INC THRX 0001032623 DRAZAN JEFFREY M C/O SIERRA VENTURES SAND HILL ROAD, SUITE 100 MENLO PARK CA 94025 1 0 0 0 3% Convertible Subordinated Notes due 2015 25.87 2011-03-02 4 S 0 1593000 1743273 D 2015-01-15 Common Stock 61577 1600000 I By Sierra Ventures VI, L.P. 3% Convertible Subordinated Notes due 2015 25.87 2011-03-03 4 S 0 1600000 1762933 D 2015-01-15 Common Stock 61848 0 I By Sierra Ventures VI, L.P. 3% Convertible Subordinated Notes due 2015 25.87 2015-01-15 Common Stock 11867 307000 I By SV Associates VI, L.P. Convertible notes are exercisable at any time prior to the close of business on the business day immediately preceding the Expiration Date. Price received includes $6,903.00 of accrued interest. Reporting Person is a general partner of SV Associates VI, L.P., which is the general partner of Sierra Ventures VI, L.P. The Reporting Person disclaims beneficial ownership of these reported securities, except to the extent of his pecuniary interest therein. Price received includes $6,933.33 of accrued interest. Convertible notes held in the name of SV Associates VI, L.P. as nominee, of which $69,906.20 represents convertible notes held in the name of SV Associates VI, L.P. as nominee on behalf of the Reporting Person. The Reporting Person disclaims beneficial ownership of these reported securities, except to the extent of his pecuniary interest therein. /s/ Jeffrey M. Drazan 2011-03-09